spec sheet12 rows
Abaloparatide (brand name Tymlos) is a synthetic peptide modeled on parathyroid hormone-related protein (PTHrP, a natural signal your body uses to manage bone and calcium). It is an approved bone-building (anabolic) treatment for osteoporosis in postmenopausal women at high risk of fracture. Unlike most osteoporosis drugs that mainly slow bone loss, abaloparatide actively tells the body to lay down new bone, which raises bone density and lowers the chance of spinal and other fractures.
- Actively builds new bone, not just slows loss
- Cuts spinal and nonvertebral fracture risk
- Raises bone mineral density fairly quickly
- Benefit holds when followed by an antiresorptive
- Dizziness or lightheadedness
- Nausea
- Raised blood calcium
Mechanism
Abaloparatide binds the PTH1 receptor, the same receptor parathyroid hormone uses, but it favors a short-lived (RG) conformation of that receptor; this gives a briefer, more selective anabolic pulse that leans toward building bone rather than breaking it down [1]. Given once daily under the skin, that daily on-off signal preferentially activates osteoblasts (the cells that build bone), increasing bone formation faster than resorption and improving both density and bone architecture [1]. In the pivotal trial it reduced new vertebral and nonvertebral fractures over eighteen months, and the benefit carried forward when patients were transitioned to a bisphosphonate afterward [1][2].
receptor fingerprint
PTH1 receptor (RG conformation)agonist
Osteoblastsactivates
Calcium / mineral handlingmodulates
Safetyrisks and cautions, not medical advice
Prescription anabolic bone agent; not a supplement. It carries class labeling around bone-tumor risk seen in animal studies, and can cause dizziness, fast heartbeat, nausea, and raised calcium. It is used under medical supervision for a limited treatment window.
Interactionsdocumented pairs only, not exhaustive
Abaloparatide is a peptide analogue of parathyroid hormone related protein, cleared by proteolysis rather than by cytochrome P450 enzymes, so it does not compete for the metabolic pathways that drive most drug interactions. The interactions worth knowing about run through calcium instead.
Each dose produces a transient rise in serum calcium that peaks a few hours later. In someone taking digoxin that matters, because hypercalcemia sensitizes the myocardium to cardiac glycosides; digitalis toxicity can appear as arrhythmia at a digoxin level that would otherwise look ordinary. The same logic applies to anything else pushing calcium upward, including thiazide diuretics and generous vitamin D or calcium supplementation, where the effects are additive.
No formal pharmacokinetic interaction studies have been conducted, and none of the reported problems involve enzyme induction or inhibition.
Checking a whole stack? Run it through interactions + stacks.
Subjective profileweighing the evidence above
A genuinely effective bone builder for postmenopausal women at high fracture risk, and one of the few options that adds bone rather than just slowing its loss. It is a prescription daily injection with bone-tumor class labeling and a limited treatment window, so it belongs entirely under a doctor.
Resources
This entry is here for reference.
Research
- 1.Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis: A Randomized Clinical Trial
- 2.ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis
2 listed here; entry last updated July 2026
Reviews
My notesprivate to this device
FAQ
How is it different from regular osteoporosis meds?
Most osteoporosis drugs are antiresorptive (they slow the cells that break bone down). Abaloparatide is anabolic, meaning it signals the body to build fresh bone, so density can climb rather than just hold steady.
How does it compare to teriparatide?
Both are anabolic peptides working through the PTH1 receptor. Abaloparatide is engineered to favor the bone-building side of that receptor and, in practice, tends to raise density with a somewhat smaller rise in calcium.
Why is it given daily?
The trick is a short daily pulse; a brief on-then-off signal favors bone formation, whereas a constant high signal would actually pull bone apart. The short half-life is part of the design.
Is it something you take forever?
No; anabolic bone agents are used for a limited window, then people are usually moved onto a maintenance drug (like a bisphosphonate) to lock in the gains.
Adverse effects
- Dizziness or lightheadedness
- Nausea
- Raised blood calcium
Notes and cautions
- Fast or pounding heartbeat